Google+ Facebook Twitter Twitter

Precision pathology for cancer with new ai tool

A new AI tool interprets medical images with unprecedented clarity, according to the results of a new study.

A molecular biologist working with a microscope in a modern scientific Laboratory, we see a computer screen in the foreground- CREDIT - istock-1390303303

The tool, called iStar (Inferring Super-Resolution Tissue Architecture), was developed by researchers at the University of Pennsylvania.

They believe that it can help diagnose and better treat cancers that might otherwise go undetected.

The imaging technique provides highly detailed views of individual cells and a broader look at the full spectrum of how people’s genes operate to identify cancer cells that might otherwise have gone undetected.

This tool can be used to determine whether safe margins were achieved through cancer surgeries and automatically provide annotation for microscopic images, paving the way for molecular disease diagnosis at that level.

The team said the iStar has the ability to automatically detect critical anti-tumour immune formations called “tertiary lymphoid structures,” whose presence correlates with a patient’s likely survival and favourable response to immunotherapy.

They claim that iStar could be a powerful tool for determining which patients would benefit most from immunotherapy.

iStar was developed using spatial transcriptomics – a relatively new field used to map gene activities within the space of tissues.

To test the efficacy of the tool, iStar was evaluated on cancer tissue types, including breast, prostate, kidney, and colorectal cancers, mixed with healthy tissues.

Within these tests, iStar was able to automatically detect tumour and cancer cells that were hard to identify just by eye.

Image credit | iStock

Related Articles

alexandra grainey and team CREDIT_Supplied

My lab: innovative cellular pathology

A guided tour of cellular pathology at One Dorset Pathology.

big question headline

What safeguards and regulations would you like to see in place for AI pathology?

With artificial intelligence (AI) becoming ever more sophisticated and prevalent across society, combined with advances in digital pathology and the fast-paced progress in deep learning, we may be on the cusp of the era of AI in pathology. However, with technical, logistical and ethical barriers in place, we look at what measures are needed before widespread clinical adoption.

student studying-CREDIT-shutterstock-717727117

Celebrating IBMS exam success

It is time to celebrate the success of more IBMS members in the Diploma of Expert Practice (DEP) or Advanced Specialist Diploma (ASD) in Histological Dissection and the DEP in Immunocytochemistry exams.


Advanced and consultant practice roles

Sarah May and Chris Ward from the IBMS look at advanced and consultant roles and discuss new developments and qualifications.